These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 12212215

  • 1. [Effect of puerarin on heart function and serum oxidized-LDL in the patients with chronic cardiac failure].
    Duan S, Li YF, Luo XL.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr 28; 25(2):176-8. PubMed ID: 12212215
    [Abstract] [Full Text] [Related]

  • 2. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 3. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Ma QL, Xie Y, Zhang SD.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec 28; 27(6):527-9. PubMed ID: 12658930
    [Abstract] [Full Text] [Related]

  • 4. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT, Li WM, Xiu CH, Shen JX, Wang X, Wu S, Kong YH.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2250-5. PubMed ID: 18167212
    [Abstract] [Full Text] [Related]

  • 5. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
    Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.
    Rev Esp Cardiol; 2004 Jan 20; 57(1):45-52. PubMed ID: 14746717
    [Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic effect of puerarin therapy on sudden deafness].
    Liu JM, Ma L, He WP.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov 05; 22(11):1044-5. PubMed ID: 12433647
    [Abstract] [Full Text] [Related]

  • 8. [Chronic cardiac insufficiency (II). Left ventricular failure with a normal ejection fraction].
    Iriarte Ezkurdia MM, Sagastagoitia Gorostiza JD.
    Rev Esp Cardiol; 1991 Oct 05; 44(8):540-52. PubMed ID: 1767110
    [No Abstract] [Full Text] [Related]

  • 9. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M.
    Am Heart J; 2007 Jun 05; 153(6):1055.e1-8. PubMed ID: 17540209
    [Abstract] [Full Text] [Related]

  • 10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A, Naderi AS.
    Acta Med Austriaca; 2004 Aug 05; 31(3):67-72. PubMed ID: 15515479
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic effect of puerarin on rats with pre-eclampsia].
    Wang C, Wang XY, Zhou S, Xiong Q.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 05; 41(2):118-20. PubMed ID: 16640862
    [Abstract] [Full Text] [Related]

  • 12. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kaski JC.
    Clin Chim Acta; 2008 Feb 05; 388(1-2):196-9. PubMed ID: 18036561
    [Abstract] [Full Text] [Related]

  • 13. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM, Zhang J, Deng B, Luo M.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 06; 85(25):1737-40. PubMed ID: 16253158
    [Abstract] [Full Text] [Related]

  • 14. [Effect of beta3-adrenoceptor antagonist on the cardiac function and expression of endothelial nitric oxide synthase in a rat model of heart failure].
    Gan RT, Li WM, Wang X, Wu S, Kong YH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov 06; 19(11):675-8. PubMed ID: 17996136
    [Abstract] [Full Text] [Related]

  • 15. [A clinical study on manshuailing oral liquid in treating elder patients with congestive heart failure of type heart and kidney yang deficiency].
    Yang DY, Wu XL, Xu H, Duan XZ, Wang SW, Lu ZZ.
    Zhongguo Zhong Yao Za Zhi; 2003 Nov 06; 28(11):1091-3. PubMed ID: 15615423
    [Abstract] [Full Text] [Related]

  • 16. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 06; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 17. Difference of baseline serum copper levels between groups of patients with different one year mortality and morbidity and chronic heart failure.
    Málek F, Dvorák J, Jiresová E, Spacek R.
    Cent Eur J Public Health; 2003 Dec 06; 11(4):198-201. PubMed ID: 14768782
    [Abstract] [Full Text] [Related]

  • 18. Determinants of left ventricular systolic function recovery after an acute coronary syndrome.
    Sampaio F, Mateus P, Bettencourt N, Dias CC, Adão L, Santos L, Teixeira M, Simões L, Gama V.
    Rev Port Cardiol; 2006 Mar 06; 25(3):321-7. PubMed ID: 16789405
    [Abstract] [Full Text] [Related]

  • 19. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.
    Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, Kalman J, Phillips RA, Steingart R, Brown EJ, Berkowitz R, Moskowitz R, Soni A, Mancini D, Bijou R, Sehhat K, Varshneya N, Kukin M, Katz SD, Sleeper LA, Le Jemtel TH, New York Heart Failure Consortium.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1432-8. PubMed ID: 15093880
    [Abstract] [Full Text] [Related]

  • 20. [Clinical investigation of the protective effects of potassium magnesium aspartate against arrhythmia and its possible anti-oxidative mechanism].
    Zhi YF, Huang YS, Xu BS, Wang SR.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov 21; 19(11):662-6. PubMed ID: 17996133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.